Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
PHARMACEUTICAL INDUSTRY
The pharmaceutical industry operates under unique circumstances: Estimates of the cost to bring a single new drug to market range from $800 million to $1.2 billion, and on average, a patent’s life remaining upon FDA launch approval is only eight years. Thus, achieving the highest level of performance is critical to pharmaceutical companies. This topic is dedicated to marketing, market research, business operations, and management issues specific to the pharmaceutical industry.
Pharmaceutical Industry is part of Business Exchange, suggested by
Ken Rhines.
This topic contains
2,138 news
and
781 blog
items.
Read updated news, blogs, and resources about Pharmaceutical Industry. Find user-submitted articles and reactions on Pharmaceutical Industry from
like-minded professionals.
Most Active
The most active stories in this topic based on user activity.
Advisors to the FDA recommended banning Vicodin and Percocet.
Microfluidics, a wholly owned subsidiary of and Particle Sciences Inc have formed a strategic alliance to help...
GlaxoSmithKline's chief executive acknowledged on Friday that overhauling its research operation was traumatic.
Teva Pharmaceutical Industries Ltd., which bought Barr Laboratories Inc. for $7.4 billion last year, is ready for...
Sanofi-Aventis SA Chief Executive Officer Chris Viehbacher says a U.S. takeover isn’t necessarily in the cards for...
Posted on Carbon Offsets Daily, Climate Counts recently released a scorecard for pharma.
The recent surge in M&A activities, with four in the first half of 2009 alone, cannot solely be attributed to the...
When President Barack Obama spoke to the American Medical Assn. on June 15, he couldn't quite quantify the potential...
India, China, Latin America and CEE as Clinical Trial Destinations As part of our Partnerships with CROs LinkedIn...
An advisory panel of the Food and Drug Administration said two leading antipsychotic medications should be approved for...
According to an article at Fierce Vaccines, the University of Sienna and Novartis Vaccines and Diagnostics will be...
Generic versions of expensive biotechnology drugs would reduce the amount of money spent on health care in the United...
The Cleveland Clinic doc is urging the federal government to back the creation of novel treatments.
The failure of a Merck drug to treat acute heart failure in a large clinical trial raises new questions about the...
Even with the Medicare drug benefit, even with the prevalence of low-cost generics, even with loss-leader discounting...
Sanofi-Aventis SA will pay $95.5 million to settle allegations that it overcharged state Medicaid programs for...
Pfizer Inc.'s (NYSE:PFE) $68 billion acquisition of Wyeth (NYSE:WYE) and Merck & Co.'s (NYSE:MRK) $41 billion bid...
Celexa, part of a class of antidepressants widely prescribed for autistic children, didn’t help reduce their repetitive...
A spike in interest in the drug Zelnorm did little to boost prescriptions.
Shares in Dublin-based biotechnology company Elan Corp. (NYSE:ELN) surged Monday in London after The Wall Street...
01.26.09, 05:30 PM EST With a megamerger that helps earnings but may hurt science, Pfizer makes a Faustian bargain with...
GE Healthcare, a subsidiary of General Electric Co. (NYSE:GE), and Fujifilm Corp. (NASDAQ:FUJI) have announced a...
Top Sources: Pharmaceutical Industry
- pharmachemicalscoatings.blogspot.com
- BusinessWeek
- bloomberg.com
- Reuters
- New York Times
- srcomblog.wordpress.com
- Industry Week
- pharmatching.com
- send2press.com
- myharvardnews.com
Tweets on this Topic












account